Investor Inquiries

Investor Relations Department
Tel: +965 2228 64444 Ext. 6475
Email:

 

Omar Fouda – Investor Relations Manager
Email:

General Inquiries

Business Development

General
Email: bd@mezzan.com

 

Pharmaceutical
Email:

Pharmacovigilance

For any safety concerns, adverse events, or complaints about Mezzan pharmaceutical products,  please contact us:

Hotline: 1833335

Email: pv.safety@mezzan.com